期刊文献+

bFGF和Ets-1表达与原发性卵巢癌生物学行为的关系

The relationship between the expression of basic fibroblast growth factor and E26 transformation-specific-1 in primary ovarian carcinoma and biological behavior
下载PDF
导出
摘要 目的检测碱性成纤维细胞生长因子 (basicfibroblastgrowthfactor ,bFGF)和E2 6转录因子 (E2 6transformation specific 1 ,Ets 1 )在原发性卵巢癌中的表达 ,为评估卵巢癌的生物学行为提供新的依据。方法应用免疫组织化学染色方法检测 32例原发性卵巢癌组织中bFGF和Ets 1的表达。结果 (1 )卵巢癌组织中bFGF和Ets 1的表达明显高于癌旁组织 (P <0 0 0 1 ) ;(2 )bFGF和Ets 1的表达与原发性卵巢癌的FIGO分期和组织学分级密切相关 ;(3)有淋巴结转移患者的bFGF和Ets 1表达高于无淋巴结转移患者 (P <0 0 0 5和P <0 0 1 ) ;(4 )癌组织中bFGF和Ets 1的表达密切相关 ,相关系数rs0 785 (P <0 0 1 )。结论bFGF和Ets 1的表达与原发性卵巢癌的生物学行为 (发展和转移等 )有关。 Objective To detect the expression of basic fibroblast growth factor (bFGF) and E26 transformation specific 1(Ets 1) in primary ovarian carcinoma to provide new evidence for understanding the biological behavior of primary ovarian carcinoma. Methods SP immunohistochemically method was used to detect the expression of bFGF and Ets 1 in primary ovarian carcinoma.Results (1)Primary ovarian carcinoma had a higher expression of bFGF and Ets 1 than those neighbouring ovarian tissue ( P <0.001). (2)Both bFGF and Ets 1 well correlated with the FIGO stage and grade of primary ovarian carcinoma. (3)The cases with metastases of omental lymph nodes had higher expression of bFGF and Ets-1 than those without metastases. (4) The correlation analysis showed that a positive correlation between bFGF and Ets 1. Conclusion The expression of bFGF and Ets 1 primary ovarian carcinoma was involved in the bilological behavior.
出处 《贵州医药》 CAS 2004年第5期396-398,共3页 Guizhou Medical Journal
关键词 原发性卵巢癌 碱性成纤维细胞生长因子 E26转录因子 免疫组织化学 肿瘤转移 血管生成 Primary ovarian carcinoma Ets 1 Immunohistochemistry Basic fibroblast growth factor
  • 相关文献

参考文献8

  • 1林卫,彭芝兰.碱性成纤维细胞生长因子在卵巢上皮性肿瘤中的表达及意义[J].中国修复重建外科杂志,1999,13(5):299-304. 被引量:26
  • 2李晓梅,张友忠,江森.卵巢癌血管生成的临床研究进展[J].实用妇产科杂志,2001,17(2):78-80. 被引量:5
  • 3Nakayama T, Ito M, Ohtsuru A, et al. Expression of the Ets-1 proto-oncogene in human thyroid tumor. Mod Pathol, 1999,12: 61-68.
  • 4Davidson B,Risberg B,Goldberg I,et al Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome. Am J Surg Pathol, 2001,25(12): 1493-1500.
  • 5Nakayama T, Ito M, Natiot S, et al. Expression of the Ets-1 proto-oncogene in human colorectal carcinoma. Mod Pathol,2001,14(5) :415-422.
  • 6Behrens P, Rothe M, Florin A, et al. Invasive properties of serous human epithelial ovarian tumors are related to Ets-I,MMP-1 and MMP expression. Int J Mol Med,2001,8(2): 149-154.
  • 7Herrera-CarlosA,Xu,Lei,et al. Expression of metastasisrelated genes in human epithelial ovarian tumors. Int J Oncol, 2002,20(1) :5-13.
  • 8Wang Q. Correlation between androgen regular expression and FGF8 mRNA levels in patient with prostate cancer and benign prostatic hypertrophy. J Clin Pathol,1999,52..29-34.

二级参考文献22

  • 1[1]Darai E,Bringuier AF,Walker CF,et al. CD31 expression in benign, borderline, and malignant epithelial ovarian tumors: An immunohistochemicaland serological analysis. Gynecol Oncol, 1998,71(1) :122~127.
  • 2[2]Orre M,Miri LM, Mamers P,et al. Increased microvessle density in mucinous compareed with malignant serous and benign tumors of the ovary. Br J Cancer, 1998,77(12): 2204~2209.
  • 3[3]Orre M, Rogers PA. Reduced vascular basement-membrane immunostaining in mucinous tumors of the ovary. Int J Cancer, 1998,79(2) :139~143.
  • 4[4]Barton DP,Cai A,Wendt K,et al. Angiogenic protein expression in advanced epithelial ovarian cancer. 1997,3(9) : 1579~1586.
  • 5[5]Abulafia O, Triest WE, Sherer DM.Angiogenesis in primary and metastatic epithelial ovarian carcinoma. Am J Obstet Gynecol.1997,133(3): 541~547.
  • 6[6]Gasparini G,Bonoldi E,Viale G,et al. Prognostic and predictive value of tumor angiogenesis in ovarian carcinomas. Int J Cancer, 1996,69(3): 205~211.
  • 7[7]Orre M,Rogers PA. VEGF,VEGFR-1,VEGFR-2,microvessle density and endothelial cell proliferation in tumors of the ovary. Int J Cancer, 1999,84(2): 101 ~108.
  • 8[8]Carzetti GG,Ciavattini A,Lucarini G,et al. Expression of vascular endothelial growth factor related to 72-kolodalton metalloproteinase immunostaining in patients with serious ovarian carcinoma.Cancer, 1999,85 (10): 2219~2225.
  • 9[9]Fujimoto J,Sakaguchi H,Hirose R,et al. Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma. Cancer, 1999,83(12): 2528~ 2533.
  • 10[10]Nakanishi Y,Kodama J,Yoshinouchi M,et al. the expression of vascular endothelial growth factor and transforming growth factor-bata association with angiogenesis in epithelial ovarian cancer.Int J Gynecol Pathol,1997,16(3):256~262.

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部